194 related articles for article (PubMed ID: 21803956)
1. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
Kubica AW; Rose PS; Weaver AL; Brewer JD
Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
3. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
5. Atypical fibroxanthoma in the setting of chronic lymphocytic leukemia and other non-Hodgkin lymphomas.
Colgan MB; Brewer JD; Weaver AL; Roenigk RK; Otley CC
Dermatol Surg; 2011 May; 37(5):671-6. PubMed ID: 21446993
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database.
Liu B; Wei H; Ren YJ; Zou D; Zhang K; Ma Q; Xiao X
PLoS One; 2020; 15(6):e0232466. PubMed ID: 32492019
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
9. Malignant fibrous histiocytoma of the spine: a series of 13 clinical case reports and review of 17 published cases.
Teng H; Xinghai Y; Wei H; Huang Q; Xiao J; Zhang C
Spine (Phila Pa 1976); 2011 Oct; 36(22):E1453-62. PubMed ID: 21343863
[TBL] [Abstract][Full Text] [Related]
10. Effect of Non-Hodgkin Lymphoma on Survival in Patients With Malignant Fibrous Histiocytoma, Kaposi Sarcoma, and Sebaceous Carcinoma: A SEER Population-Based Study.
Brewer JD; Shanafelt TD; Cerhan JR; Call TG; Weaver AL; Otley CC
Dermatol Surg; 2016 Jan; 42 Suppl 1():S32-9. PubMed ID: 26730972
[TBL] [Abstract][Full Text] [Related]
11. Pigmentary traits, sun exposure, and risk of non-Hodgkin's lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort.
Garcin LM; Gelot A; Gomez RR; Gusto G; Boutron-Ruault MC; Kvaskoff M; Severi G; Besson C
Cancer Med; 2021 Jan; 10(1):297-304. PubMed ID: 33219744
[TBL] [Abstract][Full Text] [Related]
12. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study.
McBride A; Daniel S; Driessen MT; Szende A; Choudhry A; Tian M; Ariely R; Thompson S
Leuk Res; 2021 Dec; 111():106671. PubMed ID: 34530254
[TBL] [Abstract][Full Text] [Related]
13. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
14. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
15. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Tietsche de Moraes Hungria V; Chiattone C; Pavlovsky M; Abenoza LM; Agreda GP; Armenta J; Arrais C; Avendaño Flores O; Barroso F; Basquiera AL; Cao C; Cugliari MS; Enrico A; Foggliatto LM; Galvez KM; Gomez D; Gomez A; de Iracema D; Farias D; Lopez L; Mantilla WA; Martínez D; Mela MJ; Miguel CE; Ovilla R; Palmer L; Pavlovsky C; Ramos C; Remaggi G; Santucci R; Schusterschitz S; Sossa CL; Tuna-Aguilar E; Vela J; Santos T; de la Mora O; Machnicki G; Fernandez M; Barreyro P
J Glob Oncol; 2019 Nov; 5():1-19. PubMed ID: 31774711
[TBL] [Abstract][Full Text] [Related]
17. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
[TBL] [Abstract][Full Text] [Related]
18. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
[TBL] [Abstract][Full Text] [Related]
19. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]